SCHEMBL19626486

SCHEMBL19626486

Cc1nc(-c2ccc(F)c(Cl)c2)cs1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABL1 P00519 2/20 0.59
GAA P10253 4/20 0.55
RECQL P46063 3/20 0.55
ALDH1A1 P00352 3/20 0.55
KDM4E B2RXH2 3/20 0.55
MAPT P10636 2/20 0.55
POLB P06746 2/20 0.55
HPGD P15428 1/20 0.55
ESR2 Q92731 1/20 0.55
RAB9A P51151 5/20 0.52
NPC1 O15118 4/20 0.52
SMN1; SMN2 Q16637 3/20 0.50
TSHR P16473 1/20 0.50
HSD17B10 Q99714 1/20 0.50
ROCK2 O75116 1/20 0.49
PIM1 P11309 1/20 0.49
GSK3B P49841 1/20 0.49
AURKB Q96GD4 1/20 0.49
GFER P55789 1/20 0.49
HTT P42858 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19627004 0.87 ABL1 (0.59) ABL1GAARECQLALDH1A1KDM4E
SCHEMBL1765095 0.85 MAPT (0.60) ABL1GAARECQLALDH1A1KDM4E
SCHEMBL1764691 0.85 ALDH1A1 (0.60) GAARECQLALDH1A1KDM4EMAPT
SCHEMBL8256648 0.83 GAA (0.58) GAARECQLALDH1A1KDM4EMAPT
SCHEMBL19625313 0.83 ABL1 (0.55) ABL1ALDH1A1MAPTRAB9ANPC1
SCHEMBL1801175 0.82 MPL (0.63) ABL1ALDH1A1KDM4EMAPTPOLB
SCHEMBL1765084 0.81 MAPT (0.64) GAARECQLALDH1A1KDM4EMAPT
SCHEMBL12021849 0.81 RECQL (0.58) GAARECQLALDH1A1KDM4EMAPT
SCHEMBL12021983 0.81 GAA (0.55) GAARECQLALDH1A1KDM4EMAPT
SCHEMBL1765099 0.80 ALDH1A1 (0.58) GAARECQLALDH1A1KDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170334912-A1 Purine Diones As Wnt Pathway Modulators AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2017-11-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170334912-A1 Purine Diones As Wnt Pathway Modulators WNT1, WNT3A, CTNNB1 ABL1 2004/4885GAA 4553/4885RECQL 1370/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.